Research & Publications †
( † Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)
Robert Stein, MD, is an internationally renowned surgeon and researcher. He is recognized as one of the most experienced robotic and urologic oncology (bladder, prostate and kidney cancers) surgeons in the field, and has specific interests in robotic partial nephrectomy, robotic prostatectomy, robotic cystectomy with intracorporeal neobladder/ileal conduit, in addition to adrenalectomy, nephrectomy, ureteral reimplant, and pyeloplasty. He is commonly invited to lecture at various national and international conferences and has performed and taught robotic and laparoscopic surgeries in countries including Italy, Turkey, Peru, Chile, Mexico, Columbia, India and Saudi Arabia.
Aside from his extensive robotic and cancer surgery experience, Dr. Stein has helped to introduce and actively utilizes various newer techniques including LESS (single port) surgery, robotic fluorescence (Firefly), fluorescence cystoscopy for bladder cancer (Cysview), and MRI for prostate cancer. He is also a regular contributor in the Cleveland Clinic Institutional Tumor Board and actively pursues a multidisciplinary approach to patient care involving medical and radiation oncology.
Dr. Stein is an internationally recognized researcher and has published more than 140 peer-reviewed articles in major medical journals. He has also co-authored more than 20 book chapters and is co-editor of two upcoming books on the topics of prostate cancer and LESS surgery. His research accomplishments include various basic science projects, outcomes research, meta-analyses, dry and wet lab analysis of various novel technologies, and retrospective chart reviews. His research interests center around oncology and urologic reconstructive topics. His full curriculum vitae is attached.
Dr. Stein feels that excellent care centers around a personal and mutually respectful relationship with each patient. He also feels that empathy, encouragement and effective communication are the cornerstones to providing a positive experience for the patient, doctor and entire team providing care. If you wish for a consultation with Dr. Stein, please contact his office or call for an appointment.
Laparoscopic and robotic surgery for kidney cancer, prostate cancer, and bladder cancer; adrenal lesions, UPJ and ureteric obstruction, Single port (LESS) surgery, cryoablation, elevated PSA
Innovations & Patents
Dr. Stein has been involved in the initial and ongoing use of a single-port, natural orifice approach for essentially scar-free laparoscopic surgery. This has been used for prostatectomy, nephrectomy, pyeloplasty and ureteral surgery. He has also helped to investigate and pioneer various robotic applications in kidney cancer, prostate cancer, and reconstructive surgery such as fluorescence, renal parenchymal compression, and ureteral replacement.
Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.
To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists
receive or have the right to receive royalties or (iv) its physicians/scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.
As of 12/6/2015, Dr. Stein has reported no financial relationship with industry that is applicable to this listing. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by Cleveland Clinic. To learn more about Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.
Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers’ discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias. * Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.